Biomarkers Market Capacity, Generation, Investment Trends, Regulations and Company Profiles report to 2020.

Biomarkers Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $30.6 billion by 2020, registering a CAGR of 16% during the period 2013 to 2020. Disease diagnostic remains the key application segment that is expected to reach $6.1 billion in 2020. However, application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly with the latter expected to experience a growth rate of 17.6% during 2013 and 2020.

Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/87?utm_source=openpr&utm_medium=Niranjan

Diagnostic biomarker technology is expected to change the scenario of drug development and medical practice, as technologies are metamorphosing from traditional pathophysiology/epidemiology approach to biomarker studies such as genomics and proteomic add the analysts.

Diagnostic biomarkers though are a great tool in molecular diagnostics, is facing challenges with respect to ethical and regulatory issues as these are related to a genomic pattern of an individual which needs to be extremely confidential.

This report segments the global diagnostic biomarker on the basis of diagnostic biomarker types, applications, and service. Applications market is further segments as risk assessment, molecular diagnostics, disease diagnosis, drug discovery and development, drug formulation, forensic applications, and others. The report particularly focuses on biomarkers for diagnostic applications and excludes clinical trials and research.

Purchase Inquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/87?utm_source=openpr&utm_medium=Niranjan

With respect to geography, Asia Pacific is expected to have the highest CAGR at 20.3% from 2013 to 2020. Companies profiled in this report include Roche Diagnostic Limited (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Aushon BioSystem Inc. (U.S.), Epistem Ltd. (U.K.), G.E. Healthcare Inc. (U.K)

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.